Related Experiment Video
Updated: Jan 9, 2026
Advances in Human Induced Pluripotent Stem Cell-Derived Chimeric Antigen Receptor-Expressing Natural Killer Cells
Published on: February 14, 2025
Natural killer cell therapies in cancer: innovations, challenges, and future directions
Alaa A A Aljabali1, Omar Gammoh2, Esam Qnais3
1Faculty of Pharmacy, Department of Pharmaceutics & Pharmaceutical Technology, Yarmouk University, Irbid, Jordan.
Introduction:
Natural killer (NK) cells are innate immune effectors that can eliminate malignant cells without prior sensitization. By recognizing cellular stress signals and releasing inflammatory mediators, they contribute to immune surveillance and regulation. Their therapeutic potential lies in their ability to act across donor barriers with a reduced risk of graft-related complications; however, clinical translation remains challenging due to tumor immune evasion and limited persistence in suppressive environments.
Areas Covered:
This review summarizes the biological roles of NK cells in cancer immunity and examines recent therapeutic approaches that harness their cytotoxic and regulatory properties. We discuss barriers to clinical application, including immune suppression, antigen loss, and manufacturing limitations. In addition, we highlight emerging strategies, such as gene editing, rational combination therapies, and standardized clinical trial designs, aimed at improving therapeutic efficacy.
Expert Opinion:
NK cell-based therapies represent a promising avenue in cancer immunotherapy but require carefully designed solutions to overcome their inherent limitations. Advances in biomarker-guided patient selection, integration with existing treatment modalities, and international collaboration will be critical for translating NK cell biology into effective and durable clinical outcomes.
Insights
Natural killer (NK) cells show promise for cancer immunotherapy due to their ability to target malignant cells. Overcoming challenges like tumor immune evasion and limited persistence is key to their clinical success.
Area of Science:
- Immunology
- Cancer Biology
- Therapeutics
Background:
- Natural killer (NK) cells are innate immune cells that eliminate malignant cells and regulate immune responses.
- NK cells offer therapeutic potential in cancer treatment due to their cross-donor compatibility and reduced graft complications.
- Challenges include tumor immune evasion and limited NK cell persistence in suppressive tumor microenvironments.
Purpose of the Study:
- To review the biological roles of NK cells in cancer immunity.
- To examine current therapeutic strategies utilizing NK cell properties.
- To discuss barriers and emerging solutions for NK cell-based cancer therapies.
Main Methods:
- Literature review of NK cell biology and cancer immunotherapy.
- Analysis of therapeutic approaches targeting NK cell functions.
- Discussion of clinical translation challenges and innovative strategies.
Main Results:
- NK cells play a dual role in cancer immunity, acting as effectors and regulators.
- Existing therapeutic approaches face limitations due to tumor evasion and environmental suppression.
- Emerging strategies like gene editing and combination therapies show potential.
Conclusions:
- NK cell-based therapies are a promising cancer immunotherapy strategy.
- Careful solutions are needed to overcome limitations such as immune suppression and manufacturing issues.
- Biomarker-guided selection, combination treatments, and collaboration are crucial for clinical success.
Related Concept Videos
01:27Tumor Immunotherapy
01:30Cancer Vaccines
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
01:27Cytotoxic T Cells-mediated Immune Response
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
02:57Targeted Cancer Therapies
There are several types of targeted therapies against...
02:49Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
02:50Combination Therapies and Personalized Medicine
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...